2019 ANNUAL RESULTS HIGHLIGHTS
- The revenue amounted to approximately
- The profit before tax amounted to approximately
- The profit for the year attributable to ordinary shareholders of the parent amounted to approximately
- The total assets amounted to approximately
- The equity attributable to ordinary shareholders of the parent amounted to approximately
- The return on equity was 16.65% and the return on total assets was 3.11%.
The year of 2019 was a crucial year for Universal Medical to construct a medical and health conglomerate, and push forward the implementation of strategic upgrading. Hospital group continued to expand and their medical finance business steadily developed, the foundation for building an advanced medical and health conglomerate is coming into form. In 2019, the Company revenue increased to
Further expand hospital group business
Hospital group is the most essential part of building a medical and health conglomerate. In 2019, the Company successively entered into project cooperation contracts with
As at
The Company actively extended its health industry chain around its hospital group. With respect to medical technology, the Company introduced the world's leading medical device products, and effectively improved the medical technology of hospital customers. As to their medical digitalization business, based on their member hospitals, the Company focused on three key aspects, namely Internet-based healthcare services, smart hospital solutions, and medical big data and artificial intelligence services. By so doing, the Company continuously improved its Internet-based health platform and made great efforts to build an "online+offline" service model. Regarding supply chain management, focusing on the hospital business, the Company carried out construction and deployment of a medicine supply chain system and a management platform of transparent procurement of medical supplies; it also reviewed the use of drugs and medical consumables in each hospital, continuously improved business process and standardized the centralized procurement of regional pharmaceutical supply chains.
Steady development of finance and advisory business
The Company's medical finance business mainly provides finance lease services for county-level public hospitals. In the past year, on the one hand, the Company continued to expand market development both in depth and width and continuously fortified its business foundation in the face of complicated and changing domestic and foreign financial environment and fierce market competition. On the other hand, the Company continued to strengthen risk control and actively adjusted its financing strategy, and achieved steady development of medical finance business. The Company's advisory business includes industry, equipment and financing advisory services, and clinical department upgrade services for the prevention, treatment and rehabilitation of CVA and other major diseases with high prevalence. The Company relied on its expanding medical resource platform to improve partner hospitals' medical technology service capabilities and management efficiency in accordance with specific stages of hospital operation and clinical department development's characteristics.
In 2019, the finance and advisory business recorded revenue of
In the future, Universal Medical will continue to focus on its strategic development direction in medical and healthcare sector and seize policy and market opportunities. Based on the concept of whole life cycle, the Company will strive to build a health industry closed loop centered on medical services and comprising medical finance, medical technology services, medical digitalization and industry chain extension businesses. The Company will actively explore medical and elderly care business, medical health insurance, medical engineering cooperation, regional inspection centers, logistics management and other sectors, and will continue to pool high-quality resources in the industry, improve the layout of the industry, strive to build a trustworthy medical and health conglomerate, and contribute to the construction of "Healthy China".
About
This press release is issued by
Copyright 2020 ACN Newswire . All rights reserved.
© Japan Corporate News, source